3 Inspiring MedTech Clusters in Europe
Medical technology is transforming healthcare at an unprecedented pace. From AI-powered diagnostics and connected devices to advanced imaging systems and minimally invasive treatments, MedTech innovations are helping healthcare providers deliver more personalised, efficient, and accessible care.
However, breakthroughs rarely happens in isolation. The most successful MedTech companies are often part of highly connected ecosystems where researchers, clinicians, entrepreneurs, investors, and industry leaders closely work together. These science clusters provide access to specialised facilities, talent, knowledge, and funding networks that accelerate innovation from concept to real-world impact.
Across Europe, several MedTech clusters are setting the standard for innovation. Here are three MedTech clusters from our network that are helping shape the future of healthcare technology.
Canary Wharf, East London
Traditionally known as London’s global financial centre, Canary Wharf has rapidly emerged as a leading destination for life sciences and MedTech innovation. As part of the wider East London life sciences cluster, the area combines world-class research institutions, NHS partners, regulators, and growing numbers of medical technology companies within a highly connected urban ecosystem.
One of the cluster’s greatest strengths is its proximity to key healthcare and regulatory organisations. Companies located in Canary Wharf benefit from direct access to organisations including Genomics England, Barts Health NHS Trust, the Medicines and Healthcare products Regulatory Agency (MHRA), the UK Health Security Agency, and the General Pharmaceutical Council. These organisations create a unique environment where research, clinical validation, regulation, and commercialisation can happen in close collaboration.
The scale of the wider ecosystem is impressive. The so-called East London Life Sciences Super Cluster is split between Canary Wharf and Whitechapel, and serves a highly diverse population of more than 2.5 million people with a uniquely high variation of nationalities, creating exceptional opportunities for clinical research and real-world healthcare innovation. The East London ecosystem is anchored by institutions such as Queen Mary University of London, the Royal London Hospital, and Barts Health NHS Trust, one of the largest NHS trusts in England. Together, these organisations provide access to clinical expertise, research infrastructure, healthcare data, and diverse patient populations that are vital for MedTech development and testing.
With more than 40 life sciences and healthcare organisations already based in Canary Wharf and the development of Europe’s tallest purpose-built commercial laboratory well underway, the area continues to strengthen its position as one of Europe’s most exciting locations for MedTech innovation.
Noviotech Campus, Nijmegen
Located in the Netherlands, Noviotech Campus is a unique innovation environment where healthcare and high-tech expertise come together. The campus has developed a unique position at the intersection of medical technology, digital health, biotechnology, semiconductors, and chip design. Noviotech Campus is home to more than 85 companies and organisations employing over 4,500 professionals. This concentration of expertise creates valuable opportunities for collaboration between MedTech innovators, digital health companies, researchers, and technology developers. A key differentiator of the cluster is the combination of healthcare expertise with advanced semiconductor and sensor technology.
The wider Nijmegen ecosystem further strengthens MedTech innovation through close connections with Radboud University, Radboudumc, the Donders Institute, and HAN University of Applied Sciences. These institutions contribute world-class expertise in drug development, immunology, neuroscience, AI-driven diagnostics and digital health.
By combining healthcare expertise with advanced engineering capabilities and state-of-the-art laboratories and cleanrooms, Noviotech Campus offers a powerful environment where MedTech innovations can move efficiently from development to market adoption.
Berlin-Brandenburg
Few regions in Europe combine research excellence, clinical expertise, and industrial strength as effectively as Berlin-Brandenburg. The German capital region has built one of Europe’s most advanced MedTech ecosystems and continues to demonstrate strong growth across multiple healthcare technology disciplines.
The region is home to approximately 380 medical technology companies, employing nearly 17,000 people and generating annual revenues of around €1.5 billion. Many of these companies are small and medium-sized enterprises that have become global leaders within highly specialised medical technology markets. Berlin-Brandenburg’s innovation strengths span a broad range of focus areas, including digital health, telemedicine, medical imaging, minimally invasive medicine, and organ support systems. The region also benefits from growing capabilities in AI, robotics, sensor technology, additive manufacturing, and quantum technology.
A major advantage of the cluster is its exceptional research infrastructure. The region hosts over 40 research institutions, including leading institutions such as TU Berlin and Charité – Universitätsmedizin Berlin, and various Fraunhofer, Helmholtz, Leibniz, and Max Planck institutes. These organisations create a strong pipeline for translating scientific discoveries into commercial healthcare solutions.
The healthcare infrastructure is equally significant. With more than 140 hospitals and care facilities across the region and access to public and private funding, there is a unique combination that makes the region a prime location for MedTech innovation.
Successful MedTech innovation depends on more than technological expertise alone. Companies need clinicians, researchers, regulators, investors, and specialised infrastructure to successfully bring innovations to market.
The science clusters in East London, Nijmegen, and Berlin-Brandenburg demonstrate how powerful these ecosystems can be. Each combines world-class research, healthcare expertise, industry knowledge, and collaborative communities that enable innovators to move faster from discovery to real-world healthcare impact.
At Kadans Science Partner, we understand the importance of creating environments where innovation can thrive. By providing specialised research facilities and fostering connections between organisations, we help strengthen the ecosystems that enable the next generation of MedTech breakthroughs. As healthcare systems continue to face growing challenges, the role of collaborative science clusters in accelerating innovation will only become more important.
Explore our life sciences clusters
Be inspired by innovation
From groundbreaking research to tenant milestones — stay updated on what’s happening across our European science clusters.
